In early March, the FDA granted marketing approval for use of imiquimod cream in the treatment of nonhyperkeratotic, nonhypertrophic AKs on the scalp or face in immunocompetent individuals.
Q1 Accepted NDAs and sBLAs to Keep a Watchful Eye On
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Frontline Forum Part 4: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies
The Cutaneous Connection: JAK Inhibitor Safety for Treating AD
Dupilumab Safe and Effective in Moderate-to-Severe Atopic Dermatitis
Silybum Marianum Fruit Extract Safe, Effective in Acne-Prone Skin
2 Clarke Drive Cranbury, NJ 08512